niacinamide has been researched along with Incontinentia Pigmenti Achromians in 5 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metastatic renal cell carcinoma (mRCC) has historically been refractory to cytotoxic and hormonal agents." | 1.43 | Sunitinib in metastatic renal cell carcinoma (mRCC): a developing country experience. Do our patients behave differently than the Western patients? ( Aziz, SA; Bhat, GM; Changal, KH; Lone, AR; Mir, MH, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sibaud, V | 1 |
| Robert, C | 2 |
| Mir, MH | 1 |
| Changal, KH | 1 |
| Aziz, SA | 1 |
| Bhat, GM | 1 |
| Lone, AR | 1 |
| Forbat, E | 1 |
| Al-Niaimi, F | 1 |
| Ali, FR | 1 |
| Dasanu, CA | 1 |
| Alexandrescu, DT | 1 |
| Dutcher, J | 1 |
3 reviews available for niacinamide and Incontinentia Pigmenti Achromians
| Article | Year |
|---|---|
[Pigmentary disorders induced by anticancer agents. Part II: targeted therapies].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Cetuxi | 2013 |
Use of nicotinamide in dermatology.
Topics: Acne Vulgaris; Dermatitis, Atopic; Humans; Niacinamide; Pigmentation Disorders; Pruritus; Skin Disea | 2017 |
[Cutaneous side effects of antiangiogenic agents].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzenesulfonate | 2007 |
2 other studies available for niacinamide and Incontinentia Pigmenti Achromians
| Article | Year |
|---|---|
Sunitinib in metastatic renal cell carcinoma (mRCC): a developing country experience. Do our patients behave differently than the Western patients?
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Carcinoma, Renal Cell; Developing C | 2016 |
Yellow skin discoloration associated with sorafenib use for treatment of metastatic renal cell carcinoma.
Topics: Acrodermatitis; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Erythema; Humans; K | 2007 |